EMA committee recommends approval of GSK’s RSV vaccine, Arexvy for all adults 18 years and older: London, UK Saturday, December 13, 2025, 13:00 Hrs [IST] GSK plc announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback